URO ONCO

Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Long-term outcomes among patients who achieve complete or near-complete responses after the induction phase of bladder-preserving combined modality therapy for muscle-invasive bladder cancer: A pooled analysis of RTOG 9906 and 0233

Journal of Clinical Oncology (2014) 32:4 SUPPL. 1.

Journal of Clinical Oncology (2014) 32:4 SUPPL. 1.

Comment from Maria Ribal: Bladder preserving strategies could be assumed in very well selected patients affected by muscle invasive bladder cancer. Trimodality therapy (including maximal TURb, radiotherapy and concomitant chemotherapy) is the recommended option when planning a bladder sparing approach.
For TURb assessing response to chemo-radiation therapy it is crucial to select patients that should be rescued by cystectomy and those that can be maintained in the program. Absence of tumor in TURb (T0) or minimal diseases (Ta or Tis) can be considered for bladder preservation therapy in those selected cases.

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe

URO ONCO is made possible by an unrestricted educational grant from:

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.

The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.